I. Definitions

  • Persistent Pneumonia: Persistence of clinical symptoms or radiological shadows for > 4 weeks despite appropriate antibiotic therapy.
  • Recurrent Pneumonia:
    • 2 or more episodes in a single year, OR
    • 3 or more episodes in a lifetime.
    • Key Feature: There must be radiographic clearing between episodes.

II. Differential Diagnosis (Etiology)

The causes can be categorized based on the underlying mechanism.

A. Local/Anatomic Causes (Often focal recurrence)

  1. Intraluminal Obstruction:
    • Foreign Body: Missed aspiration (Right lower lobe common).
    • Endobronchial TB or tumors (rare).
  2. Extraluminal Compression:
    • Vascular rings/slings.
    • Enlarged lymph nodes (TB, Histoplasmosis).
  3. Congenital Malformations:
    • Pulmonary Sequestration (recurrent infection in the sequestered lobe).
    • Congenital Lobar Emphysema.
    • Bronchogenic Cyst.
    • Tracheobronchial stenosis.

B. Aspiration Syndromes

  1. Oropharyngeal Dysphagia: Cerebral Palsy, Bulbar palsy.
  2. Gastroesophageal Reflux (GERD): Severe reflux + microaspiration.
  3. H-type Tracheoesophageal Fistula: Presentation often delayed.

C. Generalized/Host Defense Defects (Often diffuse/multilobar)

  1. Cystic Fibrosis (CF): Most common genetic cause of suppurative lung disease.
  2. Primary Ciliary Dyskinesia (PCD): Recurrent pneumonia + Situs Inversus + Sinusitis (Kartagener syndrome).
  3. Immunodeficiency:
    • Humoral: X-linked Agammaglobulinemia, Selective IgA deficiency.
    • Cellular: HIV/AIDS, SCID.
    • Phagocytic: Chronic Granulomatous Disease (CGD).

D. Specific Infections (Persistent)

  • Tuberculosis: Always the first differential in endemic areas.
  • Resistant Organisms: MRSA, Pseudomonas.
  • Fungal: Aspergillosis, Histoplasmosis.

III. Diagnostic Approach

Step 1: Detailed History & Examination

  • Choking history: Suspect Foreign Body.
  • Site: Same lobe (Anatomic/FB) vs Different lobes (Immune/Aspiration).
  • Associated features:
    • Greasy stools/Failure to thrive Cystic Fibrosis.
    • Ear discharge/Dextrocardia PCD.
    • Feeding difficulties Aspiration.

Step 2: Phase I Investigations (Basic)

  1. Complete Blood Count: Lymphopenia (Immune def), Neutropenia.
  2. Chest X-Ray: Compare with previous films to confirm persistence vs recurrence.
  3. Mantoux Test / IGRA: To rule out TB.
  4. Sweat Chloride Test: Gold Standard for Cystic Fibrosis (Should be done in ALL cases of recurrent pneumonia).
  5. Immunoglobulin Profile: IgG, IgM, IgA levels.
  6. HIV ELISA.

Step 3: Phase II Investigations (Anatomic/Functional)

  1. CT Scan Chest (CECT/HRCT):
    • Defines bronchiectasis, sequestration, or lymphadenopathy.
    • [Image of CT chest bronchiectasis]
  2. Flexible Bronchoscopy:
    • Visualizes airway dynamics (malacia), foreign bodies, or compression.
    • Bronchoalveolar Lavage (BAL): For culture and lipid-laden macrophages (aspiration).

Step 4: Phase III Investigations (Specific)

  • Barium Swallow: For vascular rings/TEF/GERD.
  • Nasal Nitric Oxide / Ciliary Biopsy: For PCD.
  • NBT Test / DHR Flow Cytometry: For CGD.

IV. Management

A. General Principles

  1. Treat the Acute Episode: Culture-directed antibiotics.
  2. Nutritional Rehabilitation: High-protein, high-calorie diet.
  3. Airway Clearance: Chest physiotherapy and postural drainage (crucial for CF/PCD).
  4. Vaccination: Pneumococcal (PCV/PPSV23) and Influenza vaccines.

B. Specific Management (Treat the Cause)

EtiologySpecific Management
Foreign BodyRigid Bronchoscopy and removal.
Cystic FibrosisNebulized saline/DNAse, Azithromycin, Creon enzymes, CFTR modulators.
TuberculosisAnti-tubercular therapy (ATT) as per weight bands.
Immune DeficiencyIVIG replacement (for humoral defects), prophylactic cotrimoxazole.
GERDThickened feeds, positioning, PPIs; Fundoplication if refractory.
Anatomic DefectSurgical resection (e.g., Sequestration, Cyst).
AsthmaInhaled Corticosteroids (ICS) – Asthma often mimics recurrent pneumonia (atelectasis misread as pneumonia).

C. Follow-up

  • Monitor growth velocity.
  • Pulmonary Function Tests (PFTs) in older children.
  • Repeat imaging only if clinical deterioration (ALARA principle).